Increase in the oxidized/total coenzyme Q-10 ratio in the cerebrospinal fluid of Alzheimer's disease patients - PubMed (original) (raw)
doi: 10.1159/000256209. Epub 2009 Nov 10.
Affiliations
- PMID: 19907182
- DOI: 10.1159/000256209
Increase in the oxidized/total coenzyme Q-10 ratio in the cerebrospinal fluid of Alzheimer's disease patients
Chiaki Isobe et al. Dement Geriatr Cogn Disord. 2009.
Abstract
Background/aim: The contribution of mitochondrial dysfunction and oxidative stress to the pathogenesis of Alzheimer's disease (AD) has previously been described. We aimed to investigate whether the balance between the oxidized and reduced forms of coenzyme Q-10 (CoQ-10) is related to the pathogenesis of AD.
Materials and method: Thirty patients with AD (69.0 +/- 4.1 years) and 30 healthy control subjects (63.8 +/- 16.4 years) were enrolled in this study. Concentrations of oxidized CoQ-10 and reduced CoQ-10 were measured by high-performance liquid chromatography using an electrochemical detector.
Results: The percentage of oxidized/total CoQ-10 in the cerebrospinal fluid (%CoQ-10, CSF) was significantly higher in the untreated AD group (78.2 +/- 18.8%) than in the control group (41.3 +/- 10.4%, p < 0.001), and there was a significant negative correlation between %CoQ-10 and the duration of the illness (r(s) = -0.93, p < 0.001).
Conclusion: These findings in living AD patients suggest a possible role for %CoQ-10 in the pathogenesis of the early stage of AD development.
Copyright 2009 S. Karger AG, Basel.
Similar articles
- Increase of oxidized/total coenzyme Q-10 ratio in cerebrospinal fluid in patients with Parkinson's disease.
Isobe C, Murata T, Sato C, Terayama Y. Isobe C, et al. J Clin Neurosci. 2007 Apr;14(4):340-3. doi: 10.1016/j.jocn.2005.12.023. Epub 2006 May 2. J Clin Neurosci. 2007. PMID: 16647853 - Increased mitochondrial oxidative damage in patients with sporadic amyotrophic lateral sclerosis.
Murata T, Ohtsuka C, Terayama Y. Murata T, et al. J Neurol Sci. 2008 Apr 15;267(1-2):66-9. doi: 10.1016/j.jns.2007.09.038. Epub 2007 Oct 24. J Neurol Sci. 2008. PMID: 17961597 - [Ubiquinone (UQ), coenzyme Q (CoQ)].
Ito K, Sakurai N, Yanase S. Ito K, et al. Nihon Rinsho. 2004 Dec;62 Suppl 12:206-9. Nihon Rinsho. 2004. PMID: 15658301 Review. Japanese. No abstract available. - Micronutrient special issue: coenzyme Q(10) requirements for DNA damage prevention.
Schmelzer C, Döring F. Schmelzer C, et al. Mutat Res. 2012 May 1;733(1-2):61-8. doi: 10.1016/j.mrfmmm.2011.09.004. Epub 2011 Sep 22. Mutat Res. 2012. PMID: 21964355 Review.
Cited by
- Coenzyme Q10 and Dementia: A Systematic Review.
Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JAG. Jiménez-Jiménez FJ, et al. Antioxidants (Basel). 2023 Feb 20;12(2):533. doi: 10.3390/antiox12020533. Antioxidants (Basel). 2023. PMID: 36830090 Free PMC article. Review. - Oxidative Stress and Its Clinical Applications in Dementia.
Mao P. Mao P. J Neurodegener Dis. 2013;2013:319898. doi: 10.1155/2013/319898. Epub 2012 Aug 30. J Neurodegener Dis. 2013. PMID: 26316986 Free PMC article. Review. - Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease.
de la Monte SM. de la Monte SM. Curr Alzheimer Res. 2012 Jan;9(1):35-66. doi: 10.2174/156720512799015037. Curr Alzheimer Res. 2012. PMID: 22329651 Free PMC article. Review. - Increased Albumin Oxidation in Cerebrospinal Fluid and Plasma from Alzheimer's Disease Patients.
Costa M, Horrillo R, Ortiz AM, Pérez A, Mestre A, Ruiz A, Boada M, Grancha S. Costa M, et al. J Alzheimers Dis. 2018;63(4):1395-1404. doi: 10.3233/JAD-180243. J Alzheimers Dis. 2018. PMID: 29782326 Free PMC article. - Coenzyme Q and Its Role in the Dietary Therapy against Aging.
Varela-López A, Giampieri F, Battino M, Quiles JL. Varela-López A, et al. Molecules. 2016 Mar 18;21(3):373. doi: 10.3390/molecules21030373. Molecules. 2016. PMID: 26999099 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical